Emerging Biotech
Watch on Demand! The Current State of Emerging Biotech Venture Capital & How to Successfully Raise Funds
Insights on the changes in the biotech VC landscape and tips from an investor perspective for companies fundraising now.
Bauke Anninga
Bauke is a Principal in the Biotechnology team at M Ventures. He serves on the boards of Immunitas Therapeutics, iOnctura, NanoSyrinx, and Pictor Labs. Before joining M Ventures, he was with Jefferies International in the Healthcare Investment Banking group in London (UK). During his time at Jefferies he advised on several financings and M&A transactions across the biotechnology, pharmaceutical and medical devices sectors. Bauke has a PhD in Cancer Studies from King’s College London (UK) and an MSc in Technical Medicine from the University of Twente (The Netherlands).
